Business Today
Subscribe
PMS TodayUS NewsIndiaUPSTARTWeatherBT ShortsNRIEducationElection
BT GolfBT MindrushBT Best Banks
Search

COMPANIES

No Data Found

NEWS

No Data Found
Advertisement
News
markets
stocks
Suven Pharmaceuticals Ltd
Suven Pharmaceuticals Ltd

Suven Pharmaceuticals Ltd (SUVENPHAR) Share Price

  • Sector: Pharmaceuticals (Small Cap)
  • Volume: 96,297
Apr 25, 2025
  • NSE
  • BSE
Share
  • Whatsapp
  • Twitter
  • Facebook
₹1,165.80
₹-39.00 (-3.27%)
1,145.80Low
Today’s Performance
1,219.50High
598.00Low
52 Week’s Performance
1,360.00High

bt_logoStock Analysis

bt_logoStock Performance

  • 1 Day-0.02%
  • 1 Week3.14%
  • 1 Month2.49%
  • 3 Months19.98%
  • 6 Months-4.67%
  • 1 Year87.81%
  • 3 Years28.15%
  • 5 Years52.23%

bt_logoPeer Comparison

Price

bt_logoStock Summary

  • Face Value (₹)1.00
  • Beta0.53
  • 52-Week Low (₹)598.00
  • 52-Week High (₹)1,360.00
  • Price-to-Book (X)*15.50
  • Dividend Yield (%)-
  • Price-to-Earnings (P/E) (X)*109.84
  • Earnings Per Share (₹)10.97
  • Market Cap (₹ Cr.)*30,669.99
* Values as of last close price

bt_logoCOMPETITORS

BT TV

Modi Breaks Silence After Pahalgam Terror | ‘Time To Crush Terrorists And Their Masters’3:52Modi Breaks Silence After Pahalgam Terror | ‘Time To Crush Terrorists And Their Masters’
Soft Upstream, Strong Charts! Reliance Q4: What Experts Say2:13Soft Upstream, Strong Charts! Reliance Q4: What Experts Say
Pahalgam Attack Aftermath: India Rolls Out Tough Diplomatic & Border Measures2:53Pahalgam Attack Aftermath: India Rolls Out Tough Diplomatic & Border Measures
US Treasury Slams China’s Trade Model | Urges Urgent Global Rebalancing2:55US Treasury Slams China’s Trade Model | Urges Urgent Global Rebalancing
U.S. Treasury: IMF & World Bank Have Drifted From Core Mission, Are Wasting Resources7:14U.S. Treasury: IMF & World Bank Have Drifted From Core Mission, Are Wasting Resources
The Power Of Presence - An Underrated Leadership Trait1:03The Power Of Presence - An Underrated Leadership Trait
Gold or Silver?| Jim Rogers: I’ll Buy More Gold If Prices Dip – Here’s Why0:43Gold or Silver? | Jim Rogers: I’ll Buy More Gold If Prices Dip – Here’s Why
After Pahalgam Bloodshed, India Strikes Back: Indus Treaty Halted, Borders Shut, Justice Promised3:59After Pahalgam Bloodshed, India Strikes Back: Indus Treaty Halted, Borders Shut, Justice Promised
PM Modi From Bihar Stage: “India Will Punish Pahalgam Attackers Beyond Their Imagination4:32PM Modi From Bihar Stage: “India Will Punish Pahalgam Attackers Beyond Their Imagination"
Market Masters | Kenneth Andrade On Trump Tariff Impact, Market Outlook, Sectors, Mutual Funds & More24:48Market Masters | Kenneth Andrade On Trump Tariff Impact, Market Outlook, Sectors, Mutual Funds & More
View more

bt_logoFinancial Analysis

Income Statement (₹ Cr.)

No data for consolidated quarterly .

Balance Sheet (₹ Cr.)

No data for consolidated quarterly .

Cash Flow (₹ Cr.)

No data for consolidated quarterly .

bt_logoRatio Analysis

Return on Equity (%)
No Data For consolidated ROE.
Return on Assets (%)
No Data For consolidated ROE.
Price-to-Earnings (P/E) (X)
No Data For consolidated ROE.
Price to Book (x)
No Data For consolidated ROE.
Return on Capital Employed (%)
No Data For consolidated ROE.
Enterprise Value to EBITDA (X)
No Data For consolidated ROE.
Net Profit Margin (%)
No Data For consolidated ROE.
Gross Profit Margin (%)
No Data For consolidated ROE.
EBITDA Margin (%)
No Data For consolidated ROE.

bt_logoShare Holding Pattern

Summary (As on 31 Mar 2025)

bt_logoDeals

25 Jan, 2024BUY
SOCIETE GENERALE
Qty297913
Average Price₹685.15
25 Jan, 2024BUY
MARSHALLWACEINVESTMENTSTRATEGIESMARKETNEUTRALTOPSFUND
Qty176249
Average Price₹685.15
25 Jan, 2024BUY
MARSHALL WACE INVESTMENT STRATEGIESGTOPS FUND
Qty7449
Average Price₹685.15
25 Jan, 2024SELL
BNP PARIBAS ARBITRAGE
Qty297913
Average Price₹685.15
25 Jan, 2024SELL
BNP PARIBAS ARBITRAGE
Qty183698
Average Price₹685.15
17 Oct, 2022BUY
ISHARES CORE MSCI EMERGING MARKETS ETF
Qty503350
Average Price₹406.4
*Single trade that involves transaction of a minimum quantity of 5 lakh shares or a minimum value of ₹ 10 crore.

bt_logoFAQ's

What was Suven Pharmaceuticals Ltd share price previously?
Suven Pharmaceuticals Ltd share price was down by -3.27% from the previous closing price of ₹1,204.80.
Who are peers of Suven Pharmaceuticals Ltd?
The peers of Suven Pharmaceuticals Ltd are Sun Pharmaceutical Industries Ltd, Divis Laboratories Ltd, Cipla Ltd, Torrent Pharmaceuticals Ltd, Mankind Pharma Ltd, Dr Reddys Laboratories Ltd, Lupin Ltd, Zydus Lifesciences Ltd, Aurobindo Pharma Ltd, Alkem Laboratories Ltd.
Who is/are the promoter/promoters of Suven Pharmaceuticals Ltd?
The promotor/promotors of Suven Pharmaceuticals Ltd are Shweta Jalan, U B Pravin Rao, Venkatanaga Kali Vara Prasad Raju Vetukuri, Pankaj Patwari, Matangi Gowrishankar, Vinod Rao, K G Ananthakrishnan, VIVEK SHARMA, Kundan Kumar Jha, Jaishankar Krishnan, Vinod Padikkal.
What has been 52-week high of Suven Pharmaceuticals Ltd stocks?
The highest price of Suven Pharmaceuticals Ltd stock is ₹1,360.00 in the last 52-week.
What is the share price of Suven Pharmaceuticals Ltd (SUVENPHAR) today on NSE?
As on Apr 25, 2025 Suven Pharmaceuticals Ltd (SUVENPHAR)’s share price on NSE is Rs 1165.8
What is the market cap of Suven Pharmaceuticals Ltd (SUVENPHAR)?
The current market capitalisation of Suven Pharmaceuticals Ltd (SUVENPHAR) is 30,669.99 crores
What is Suven Pharmaceuticals Ltd Share symbol?
The symbol of Suven Pharmaceuticals Ltd is SUVENPHAR.
What is the PE ratio of Suven Pharmaceuticals Ltd (SUVENPHAR)?
The current PE ratio of Suven Pharmaceuticals Ltd (SUVENPHAR) is 109.84.
What is the PB ratio of Suven Pharmaceuticals Ltd (SUVENPHAR)?
The current PB ratio of Suven Pharmaceuticals Ltd (SUVENPHAR) is 15.50.
Today’s High & Low share prices of Suven Pharmaceuticals Ltd (SUVENPHAR) on NSE?
Today, the share price of Suven Pharmaceuticals Ltd (SUVENPHAR) on NSE touched a high of Rs 1219.5 and a low of Rs 1145.8
What price did Suven Pharmaceuticals Ltd (SUVENPHAR) shares open on the NSE today?
On NSE, the share price of Suven Pharmaceuticals Ltd (SUVENPHAR) opened at Rs 1208
What is the 52-week high of Suven Pharmaceuticals Ltd (SUVENPHAR)?
The 52-week high price of Suven Pharmaceuticals Ltd (SUVENPHAR) is Rs 1,360.00
What is the 52-week low of Suven Pharmaceuticals Ltd (SUVENPHAR)?
The 52-week low price of Suven Pharmaceuticals Ltd (SUVENPHAR) is Rs 598.00

bt_logoAbout Suven Pharma

Suven Pharmaceuticals Ltd, incorporated in the year 2018, has its registered office in 8-2-334 SDE Serene Chambers, 3 Floor Avenue 7 Road No 5, Hyderabad, Telangana, 500034, 91-40-23549414/1142/3311, 91-40-23541152. The main industry in which Suven Pharmaceuticals Ltd operates is Pharmaceuticals - Indian - Bulk Drugs & Formln.

Auditor/Auditors for Suven Pharmaceuticals Ltd is/are Karvy & Co/Walker Chandiok & Co LLP. In the main management, VIVEK SHARMA is chairman and Kundan Kumar Jha is the company secretary for Suven Pharmaceuticals Ltd.

  • SJ
    Shweta JalanNon Executive Director
  • UBPR
    U B Pravin RaoIndependent Director
  • VKVPRV
    Venkatanaga Kali Vara Prasad Raju VetukuriManaging Director
  • PP
    Pankaj PatwariNon Executive Director
  • MG
    Matangi GowrishankarIndependent Director
  • VR
    Vinod RaoIndependent Director
  • KGA
    K G AnanthakrishnanIndependent Director
  • VS
    VIVEK SHARMAExecutive Chairman & Director
  • KKJ
    Kundan Kumar JhaCompany Sec. & Compli. Officer
  • JK
    Jaishankar KrishnanAdditional Director
  • VP
    Vinod PadikkalAdditional Director

bt_logoTop Stories

DATA SOURCES: Corporate data, historical price & volume data published on this website have been sourced from CMOTS Internet Technologies Pvt. Ltd. BSE Quotes and NSE Quotes have been sourced from BSE Limited and NSE Data & Analytics Limited, respectively. All timestamps reflected here are in IST (Indian Standard Time). Stock Analysis section has been sourced from the mentioned partners.

DISCLAIMER: Any and all content on this website, including the tools/ analysis, is provided to you only for convenience and on an “as-is, as-available” basis without representation and warranties of any kind. The content and any output of such tools/ analysis is for informational purposes only and should not be relied upon or construed as investment advice or guarantee for any specific performance/ returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.

By using this website, you agree to the Terms of Service and Privacy Policy.